| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 28, 2010Reveal(R) Plus Study Results Published Today in Circulation
MINNEAPOLIS, Sep 28, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the publication of results from a multicenter, prospective study that demonstrated that the company's Reveal(R)
-
Sep 20, 2010Superior Deliverability Distinguishes New Medical Device Based on Engineering Advance of Continuous Sinusoid Technology
MINNEAPOLIS, Sep 20, 2010 (BUSINESS WIRE) -- Delivering another innovation for interventional cardiology, Medtronic, Inc. (NYSE: MDT), announced today the U.S. Food and Drug Administration (FDA)...
-
Sep 20, 2010Consistent Results in More Than 3,600 Patients from Complex Daily Practice of Interventional Cardiology Strengthen Evidence on Implantable Heart Device
WASHINGTON, Sep 22, 2010 (BUSINESS WIRE) -- Coronary artery disease, a leading cause of death and poor quality of life worldwide, runs the gamut from simple to complex, which complicates the daily...
-
Sep 17, 2010Initial Results Suggest ONS Warrants Further Study for Control of Chronic Migraine
MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced that data from a multicenter, prospective, randomized, blinded, feasibility trial published today show promise...
-
Sep 17, 2010Interventional Cardiology Meeting Features New Data on Resolute(R) Drug-Eluting Stent, IN.PACT(TM) Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve
MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Representing the broadest range of medical technology for the interventional treatment of cardiovascular disease,Medtronic, Inc. (NYSE: MDT), today...